DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER

Application of dabigatran etexilate for prevention of cardioembolic complications in nonvalvular atrial fibrillation is considered. Results of randomized clinical trials on efficacy and safety of dabigatran in various doses are discussed. Besides, a comparison of dabigatran and varfarin therapies is...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: I. S. Yavelov
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Reeks:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Onderwerpen:
atrial fibrillation
dabigatran
randomized clinical trials
Online toegang:https://www.rpcardio.com/jour/article/view/991
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items